17.7 C
Monday, October 18, 2021

Merck’s Covid-19 pill cuts hospitalisations by 50%, according to study

Pharmaceutical company Merck has said they will seek authorisation in the United States for an oral drug to combat Covid-19.

The new drug reduced the risk of hospitalisation or death when administered to high-risk patients early in the disease.


Merck said in a statement: “At the interim analysis, 7.3% of patients who received molnupiravir were hospitalised through Day 29, compared with 14.1% of placebo-treated patients who were hospitalised or died.”

There were no deaths in people who took the drug.

“Merck plans to seek emergency use authorisation in the US as soon as possible and to submit applications to regulatory agencies worldwide,” the company said.


If granted authorisation, molnupiravir will be the first approved oral antiviral medication for Covid-19.


An Garda Síochána says it has prevented 75 assassinations since 2016

An Garda Síochána has announced the police force has thwarted 75 assassinations in the period from 2016 to 2020.

Pubs are ‘perfectly happy’ to continue using vaccine certs – LVA

Head of the Licensed Vintners Association (LVA) Donall O'Keefe has stated that pubs are 'perfectly happy' to continue working with the use...

Former US Secretary of State Colin Powell dies following Covid-19 complications

Colin Powell has died at the age of 84 following being diagnosed with Covid-19. Powell was the first Black...

School closes after more than 30 cases of Covid-19 detected

A primary school in Wexford has closed until after the mid-term break, following more than 30 cases of Covid-19 detected at the...
overcast clouds
17.7 ° C
19.1 °
16.3 °
86 %
100 %
18 °
17 °
11 °
9 °
10 °